Unichem Laboratories has got approval from the US health regulator for its Montelukast Sodium tablets that are used in prevention and chronic treatment of asthma.

Unichem Laboratories said in a BSE filing that “the company has received ANDA approval for Motelukast Sodium tablets from the United States Food and Drug Administration (USFDA).”

It further said that the product will be commercialized from the company’s Goa plant.

Read EquityPandit’s Technical Analysis on CNX Pharma